`
`This protective order governs the treatment and filing of confidential information,
`
`including documents and testimony.
`
`1.
`
`Confidential information shall be clearly marked “CONFIDENTIAL
`
`BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER” or
`
`“CONFIDENTIAL BUSINESS INFORMATION.”
`
`2.
`
`Confidential information is information which concerns or relates to
`
`the trade secrets, processes, operations, style of work, or apparatus, or to the
`
`production, sales, shipments, purchases, transfers, identification of customers,
`
`inventories, amount or source of any income, profits, losses, or expenditures of
`
`any person, firm, partnership, corporation, or other organization, or other
`
`information of commercial value, the disclosure of which is likely to have the
`
`effect of either (i) impairing the PTAB's ability to obtain such information as is
`
`necessary to perform its statutory functions; or (ii) causing substantial harm to
`
`the competitive position of the person, firm, partnership, corporation, or other
`
`organization from which the information was obtained, unless the PTAB is
`
`required by law to disclose such information.
`
`3.
`
`Access to confidential information is limited to the following
`
`individuals who have executed the acknowledgment appended to this order:
`
`- 1 -
`
`APPLE 1035
`Apple v. Masimo
`IPR2022-01291
`
`
`
`
`
`
`
`
`
`
`
`A. Outside Counsel. Outside counsel of record for a party in the
`
`proceeding.
`
`B.
`
`Experts. Retained experts of a party in the proceeding who further
`
`certify in the Acknowledgement that they are not a competitor to any
`
`party, or a consultant for, or employed by, such a competitor with
`
`respect to the subject matter of the proceeding.
`
`No less than 10 days prior to the initial disclosure to an expert of any confidential
`
`information, the party proposing to use such expert shall submit in writing the
`
`name of such expert and his or her educational and detailed employment history to
`
`the supplier. If the producing party objects to the disclosure of such confidential
`
`business information to such expert as inconsistent with the language or intent of
`
`this order or on other grounds, it shall notify the other party in writing of its
`
`objection and the grounds therefore prior to the initial disclosure. If the dispute is
`
`not resolved on an informal basis within ten days of receipt of such notice of
`
`objections, the party seeking access to the confidential information shall arrange
`
`for a conference call with the PTAB to resolve the dispute. Absent an order from
`
`the PTAB, the expert shall not have access to the confidential information.
`
`C.
`
`Support Personnel. Administrative assistants, clerical staff, court
`
`reporters and other support personnel of the foregoing persons who
`
`are reasonably necessary to assist those persons in the proceeding
`
`- 2 -
`
`
`
`
`
`
`
`
`
`shall not be required to sign an Acknowledgement, but shall be
`
`informed of the terms and requirements of the Protective Order by the
`
`person they are supporting who receives confidential information.
`
`D.
`
`The Office. Employees and representatives of the United States
`
`Patent and Trademark Office who have a need for access to the
`
`confidential
`
`information shall have such access without
`
`the
`
`requirement to sign an Acknowledgement. Such employees and
`
`representatives shall include the Director, members of the Board and
`
`their clerical staff, other support personnel, court reporters, and other
`
`4.
`
`A.
`
`persons acting on behalf of the Office.
`
`Development Bar.
`
`“Relevant Technology” means technology related to non-invasive
`
`monitoring of pulse oximetry, total hemoglobin, oxygen content,
`
`carboxyhemoglobin, and/or methemoglobin.
`
`B.
`
`REMOVED
`
`C. Unless otherwise permitted in writing between Supplying Party and
`
`Receiving Party, any expert retained on behalf of a party who is to be
`
`given access to any material from another party showing or
`
`describing the technical functionality of products produced by
`
`another party must agree in writing not to be involved in creating,
`
`- 3 -
`
`
`
`developing, or modifying, for commercial use (which, for the
`
`avoidance of doubt, does not include academic research which is not
`
`for industry), any Relevant Technology from the time of first receipt
`
`of such confidential material through one year after the date the
`
`expert formally withdraws from the Protective Order. For avoidance
`
`of doubt, during periods in which the individual person(s) has ceased
`
`to have possession of such material or any documents or notes
`
`reflecting such material, this section shall not apply.
`
`5.
`
`Persons receiving confidential information shall use reasonable
`
`efforts to maintain the confidentiality of the information, including:
`
`A. Maintaining such information in a secure location to which persons
`
`not authorized to receive the information shall not have access;
`
`B. Otherwise using reasonable efforts to maintain the confidentiality of
`
`the information, which efforts shall be no less rigorous than those the
`
`recipient uses to maintain the confidentiality of information not
`
`received from the disclosing party;
`
`C.
`
`Ensuring that support personnel of the recipient who have access to
`
`the confidential information understand and abide by the obligation
`
`to maintain the confidentiality of information received that is
`
`designated as confidential; and
`
`- 4 -
`
`
`
`D.
`
`Limiting the copying of confidential information to a reasonable
`
`number of copies needed for conduct of the proceeding and
`
`maintaining a record of the locations of such copies.
`
`6.
`
`Persons receiving confidential information shall use the following
`
`procedures to maintain the confidentiality of the information:
`
`
`
`A.
`
`(i)
`
`Documents and Information Filed With the Board.
`
`A party may file documents or information with the Board along with
`
`a Motion to Seal. The Motion to Seal should provide a non-confidential
`
`description of the nature of the confidential information that is under seal,
`
`and set forth the reasons why the information is confidential and should not
`
`be made available to the public. A party may challenge the confidentiality of
`
`the information by opposing the Motion to Seal. The documents or
`
`information shall remain under seal unless the Board determines that some
`
`or all of it does not qualify for confidential treatment.
`
`(ii) Where confidentiality is alleged as to some but not all of the
`
`information submitted to the Board, the submitting party shall file
`
`confidential and non-confidential versions of its submission, together with a
`
`Motion to Seal the confidential version setting forth the reasons why the
`
`information redacted from the non-confidential version is confidential and
`
`should not be made available to the public. A party may challenge the
`
`- 5 -
`
`
`
`confidentiality of the information by opposing the Motion to Seal. The non-
`
`confidential version of the submission shall clearly indicate the locations of
`
`information that has been redacted. The confidential version of the
`
`submission shall be filed under seal. The redacted information shall remain
`
`under seal unless the Board determines that some or all of the redacted
`
`information does not qualify for confidential treatment.
`
`B.
`
`Documents and Information Exchanged Among the Parties.
`
`Documents (including deposition transcripts) and other information
`
`designated as confidential that are disclosed to another party during
`
`discovery or other proceedings before the Board shall be clearly
`
`marked as “CONFIDENTIAL BUSINESS
`
`INFORMATION,
`
`SUBJECT TO PROTECTIVE ORDER” or “CONFIDENTIAL
`
`BUSINESS INFORMATION” and shall be produced in a manner
`
`that maintains its confidentiality.
`
`
`
`
`
`7. Within 60 days after the final disposition of this action, including
`
`the exhaustion of all appeals and motions, each party receiving confidential
`
`information must return, or certify the destruction of, all copies of the
`
`confidential information to the producing party.
`
`- 6 -
`
`
`
`8.
`
`Acknowledgement of Protective Order. Exhibit A may be used to
`
`
`
`acknowledge the protective order and gain access to information covered by the
`
`protective order.
`
`- 7 -
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Exhibit A
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`APPLE INC.,
`Petitioner,
`
`v.
`
`MASIMO CORPORATION,
`Patent Owner.
`
`Case IPR2022-01291
`U.S. Patent 10,687,745
`
`Acknowledgment for Access to Protective Order Material
`, affirm that I have read
`
`I
`
`the Protective Order; that I will abide by its terms; that I will use the confidential
`
`information only in connection with this proceeding and for no other purpose; that
`
`I will only allow access to support staff who are reasonably necessary to assist me
`
`in this proceeding; that prior to any disclosure to such support staff I informed or
`
`will inform them of the requirements of the Protective Order; that I am personally
`
`responsible for the requirements of the terms of the Protective Order and I agree to
`
`submit to the jurisdiction of the Office and the United States District Court for the
`
`- 8 -
`
`
`
`Eastern District of Virginia for purposes of enforcing the terms of the Protective
`
`Order and providing remedies for its breach.
`
`[Signature]
`
`
`
`- 9 -
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`